Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 270213, 8 pages
http://dx.doi.org/10.1155/2014/270213
Research Article

Effects of Recombinant Human Thyrotropin Administration on 24-Hour Arterial Pressure in Female Undergoing Evaluation for Differentiated Thyroid Cancer

1Endocrine Unit, Department Medical Therapeutics, Alexandra Hospital, Athens University School of Medicine, 80 Vass Sofias Avenue, 11528 Athens, Greece
2Endocrine Unit, Evgenidion Hospital, Athens University School of Medicine, 80 Vass Sofias Avenue, Athens, Greece
3Hypertension Unit, Department of Medical Therapeutics, Alexandra Hospital, Athens University School of Medicine, 80 Vass Sofias Avenue, 11528 Athens, Greece
4Vascular Laboratory, Department of Medical Therapeutics, Alexandra Hospital, Athens University School of Medicine, 80 Vass Sofias Avenue, 11528 Athens, Greece

Received 17 February 2014; Revised 28 July 2014; Accepted 29 July 2014; Published 18 August 2014

Academic Editor: Mario Maggi

Copyright © 2014 Gianna Rentziou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Gianna Rentziou, Katerina Saltiki, Efstathios Manios, et al., “Effects of Recombinant Human Thyrotropin Administration on 24-Hour Arterial Pressure in Female Undergoing Evaluation for Differentiated Thyroid Cancer,” International Journal of Endocrinology, vol. 2014, Article ID 270213, 8 pages, 2014. https://doi.org/10.1155/2014/270213.